Market Access

Hear from PFS industry leaders from big pharma & government bodies

Pre-Filled Syringes and Injectable Drug Devices

Hear from PFS industry leaders from big pharma & government bodies

https://pharmaphorum.com/partner-content/hear-from-pfs-industry-leaders-from-big-pharma-government-bodies/

SMi’s 2nd Annual Pharmaceutical Microbiology East Coast Conference

SMi’s Pharmaceutical Microbiology East Coast

SMi’s 2nd Annual Pharmaceutical Microbiology East Coast Conference

https://pharmaphorum.com/events/smis-2nd-annual-pharmaceutical-microbiology-east-coast-conference/

NICE okays UCB’s Cimzia, nixes Almirall’s Ilumetri, in psoriasis

https://pharmaphorum.com/news/nice-okays-ucbs-cimzia-nixes-almirall-ilumetri-in-psoriasis/

Boehringer Ingelheim axes biosimilars development outside US

Boehringer Ingelheim has said it has axed ex-US development of its biosimilars, focusing instead on getting its Humira

Boehringer Ingelheim axes biosimilars development outside US

https://pharmaphorum.com/news/boehringer-ingelheim-axes-biosimilars-development-outside-us/

Precision Medicine Congress in Berlin on the 10th and 11th of April

The 2019 event will take place in Germany

Precision Medicine Congress in Berlin on the 10th and 11th of April

https://pharmaphorum.com/events/precision-medicine-congress-in-berlin-on-the-10th-and-11th-of-april/

Registration opens for the 11th Adaptive Designs in Clinical Trials

Adaptive Designs in Clinical Trials 2019

Registration opens for the 11th Adaptive Designs in Clinical Trials

https://pharmaphorum.com/partner-content/registration-opens-for-the-11th-adaptive-designs-in-clinical-trials/

Interview Released with James Mellman, Novartis

Pre-Filled Syringes Europe 2019

Interview Released with James Mellman, Novartis

https://pharmaphorum.com/partner-content/interview-released-with-james-mellman-novartis/

Predictions for 2019: Ten trends that will shape the future of drug development and commercialization

eBook Provides Biopharma Decision Makers With What’s Next Insights to Navigate Challenges and Capitalize on the Opportunities Ahead

Predictions for 2019: Ten trends that will shape the future of drug development and commercialization

https://pharmaphorum.com/partner-content/press-releases/predictions-for-2019-ten-trends-that-will-shape-the-future-of-drug-development-and-commercialisation/

NICE approves Bayer’s liver cancer drug

NICE has given Bayer’s advanced liver cancer therapy Stivarga (regorafenib) the go-ahead after it undertook a rapid review

NICE approves Bayer’s liver cancer drug

https://pharmaphorum.com/news/nice-approves-bayers-liver-cancer-drug/

1 2 3 4 5 >»

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Search

Advanced Search

Trending

Market Access